Angiodynamics (ANGO) Assets (2011 - 2026)

Angiodynamics (ANGO) has 16 years of Assets data on file, last reported at $260.7 million in Q1 2026.

• For the quarter ending Q1 2026, Assets fell 8.67% year-over-year to $260.7 million; the trailing twelve-month figure through Feb 2026 stood at $260.7 million (down 8.67% YoY), and the FY2025 full-year result was $280.1 million, down 11.81% from the prior year.
• Assets for Q1 2026 stood at $260.7 million, down from $269.7 million in the prior quarter.
• Across five years, Assets topped out at $558.2 million in Q4 2022 and bottomed at $260.7 million in Q1 2026.
• The 5-year median for Assets is $324.8 million (2024), against an average of $404.1 million.
• The widest annual swing landed in 2022, when Assets increased 0.74%; it then slumped 41.65% in 2024.
• A 5-year view of Assets shows it stood at $558.2 million in 2022, then slipped by 10.49% to $499.6 million in 2023, then plunged by 41.65% to $291.6 million in 2024, then retreated by 7.5% to $269.7 million in 2025, then dropped by 3.34% to $260.7 million in 2026.
• The last three Assets figures came in at $260.7 million (Q1 2026), $269.7 million (Q4 2025), and $265.6 million (Q3 2025), per Business Quant data.

Peer Comparison